Avalo Therapeutics
Amanda Onuskanich serves as the Senior Director of Clinical Project Management at Avalo Therapeutics since September 2025. Previously, Amanda held the role of Senior Director in Research & Development Program Management at Marinus Pharma, where responsibilities included leading project management for the Oral GNX Franchise and collaborating on cross-functional development strategies. Amanda has a diverse background, having served as the Director of Research & Development Program Management at Verrica Pharmaceuticals and as an Associate Director in Chemistry, Manufacturing, and Controls. Other roles include positions at Pharmica Consulting Inc/Otsuka US Digital Medicine Team, merganser biotech, Onconova Therapeutics, Emerson Resources, and Merck, contributing expertise in regulatory project management, product formulation, and analytical chemistry throughout various stages of drug development.
This person is not in any teams
This person is not in any offices
Avalo Therapeutics
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.